The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies
Current knowledge is summarized regarding the eicosanoid signaling network, based upon data available in one of the larger publicly available pathway databases (the Kyoto Encyclopedia of Genes and Genomes; KEGG). Several different classes of lipid-derived signaling molecules are represented within this network. They include prostaglandins, prostacyclin, thromboxane, hydroperoxyeicosatetraenoic acids, leukotrienes, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids. Prostaglandins are 20-carbon unsaturated carboxylic acids containing a cyclopentane ring. Prostaglandin (PG) synthesis can be summarized as follows. AA is converted to PGG by a cylcooxygenase, and then to PGH by a peroxidase. Both endoperoxides (PGG and PGH) are chemically unstable. In most tissues, they are subsequently converted to two hydroxyl ketones (PGD and PGE), interrelated by the activity of tissue isomerases. In some tissues, a specific hydroxyl ketone, PGE2, can be further converted to the PGFα prostaglandin series (1,3-diols) by a 9-keto reductase. PGA, PGB, PGC are lab artifacts. Prostacyclin (PGI2) and thromboxane (TXA2) are also synthesized from an endoperoxide, PGH2, via prostacyclin synthase and thromboxane synthase respectively. The relative balance of each is highly tissue specific. While both PGI2 and TXA2 are biologically active, both are rapidly inactivated to stable compounds (6-keto PGF 1α and TXB2). Leukotrienes are synthesized through a different branch within this network. At the “decisions point,” AA is oxidized to a series of hydroperoxyeicosatetraenoic acids or HPETEs (5-HPETE and 12-HPETE). HPETEs are unstable (analogous to PGG and PGH), and further metabolized by a variety of enzymes to form the leukotrienes [Hines and McCarver, 2006]. Through the combined activity of 5-lipoxygenase (ALOX-5) and 5-lipoxygenase activating protein (FLAP), AA is converted to an unstable intermediate called leukotriene A4 (LTA4). LTA4 is subsequently converted to a series of cysteinyl leukotrienes by a glutathione S-transferase (LTC4), a γ-glutamyl transpeptidase (LTD4), and a dipeptidase (LTE4). In general, these cysteinyl leukotrienes induce relaxation of vascular smooth muscle and constriction of bronchiolar smooth muscle. They have also been shown to alter endothelial function, immune function and vascular permeability.
Publication
The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies. (2008) R.A. Wilke, et al. Curr Pharmacogenomics Person Med. 2008;6(3):150-159. Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Drosophila melanogaster | Invertebrates | RR | RR | ncbigene_symbol | rr | 250607 |
| Drosophila melanogaster | Invertebrates | НЕТЕ | ET | ncbigene_symbol | et | 32975 |
| Drosophila melanogaster | Invertebrates | НЕТЕ | EE | ncbigene_symbol | ee | 45290 |
| Drosophila melanogaster | Invertebrates | АНЕТЕ | AE | ncbigene_symbol | Ae | 247444 |
| Drosophila melanogaster | Invertebrates | АНЕТЕ | ATE | ncbigene_synonym | Ate1 | 37288 |
| Drosophila melanogaster | Invertebrates | НЕTE | TE | ncbigene_symbol | te | 252809 |
| Drosophila melanogaster | Invertebrates | НРЕТЕ | PE | ncbigene_symbol | pe | 252319 |
| Drosophila melanogaster | Invertebrates | НРЕТЕ | PTE | ncbigene_symbol | pte | 252457 |
| Drosophila melanogaster | Invertebrates | NR) | NR | ncbigene_symbol | nr | 5656957 |
| Drosophila melanogaster | Invertebrates | LBL- | LBL | ncbigene_symbol | lbl | 42541 |
| Drosophila melanogaster | Invertebrates | LBL- | LBL | ncbigene_synonym | lbm | 35623 |
| Drosophila melanogaster | Invertebrates | LBL- | LBL | ncbigene_synonym | l(3)89Ea | 49073 |
| Drosophila melanogaster | Invertebrates | CKIE | CKIE | ncbigene_synonym | dco | 43673 |
| Drosophila melanogaster | Invertebrates | PGI: | PGI | ncbigene_symbol | Pgi | 35886 |
| Drosophila melanogaster | Invertebrates | PGD: | PGD | ncbigene_symbol | Pgd | 31185 |
| Drosophila melanogaster | Invertebrates | As | AS | ncbigene_symbol | as | 45825 |
| Homo sapiens | Primates | 114.153|CYP4F | CYP4F | ncbigene_synonym | CYP4F3 | 4051 |
| Homo sapiens | Primates | АНЕТЕ | ATE | ncbigene_synonym | ATM | 472 |
| Homo sapiens | Primates | НЕTE | HTE | ncbigene_synonym | ACOT8 | 10005 |
| Homo sapiens | Primates | НРЕТЕ | PEE | ncbigene_synonym | PEE1 | 5177 |
| Homo sapiens | Primates | CKIE | CKIE | ncbigene_synonym | CSNK1E | 1454 |
| Homo sapiens | Primates | PGI: | PGI | ncbigene_synonym | BGN | 633 |
| Homo sapiens | Primates | PGI: | PGI | ncbigene_synonym | GPI | 2821 |
| Homo sapiens | Primates | PGI: | PGI | ncbigene_synonym | PGPEP1 | 54858 |
| Homo sapiens | Primates | PGD: | PGD | ncbigene_symbol | PGD | 5226 |
| Homo sapiens | Primates | PGD: | PGD | ncbigene_synonym | PHGDH | 26227 |
| Homo sapiens | Primates | PGF. | PGF | ncbigene_symbol | PGF | 5228 |
| Homo sapiens | Primates | THETA | THETA | ncbigene_synonym | GABRQ | 55879 |
| Homo sapiens | Primates | diols | DIO1 | ncbigene_symbol | DIO1 | 1733 |
| Homo sapiens | Primates | diols | DIO1 | ncbigene_synonym | DIDO1 | 11083 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| ARACHIDONIC ACID | NA | mesh:D001095 | ||
| HETE | Hydroxyeicosatetraenoic Acids | mesh:D006893 | HETE | chebi:36275 |
| 12-Keto-LTB LTB4 | Leukotriene B4 | mesh:D007975 | leukotriene B4 | chebi:15647 |
| Linoleic acid | NA | mesh:D008041 | ||
| PGE | Prostaglandins E | mesh:D011458 | prostaglandins E | chebi:26338 |
| PGG | Prostaglandins G | mesh:D011462 | prostaglandins G | chebi:26343 |
| 20-OH-LTE404L4134 | Leukotriene E4 | mesh:D017999 | leukotriene E4 | chebi:15650 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|